NuBloom vs Peter MD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Women seeking a physician-founded, whole-person GLP-1 and hormone program with optional 1:1 coaching.
- semaglutide
- From $149/molowest dose rung
- tirzepatide
- From $279/molowest dose rung
Before enrolling
Compounding pharmacy partners are not named anywhere on the site — a transparency gap
Desk Score
Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes.
- semaglutide
- $149/mointro + renewal; see terms
- tirzepatide
- $249/moquarterly term
Before enrolling
Tirzepatide steps up after month one — $149 for the first month, then $249/mo billed quarterly
Our review of Peter MD gives it 77/100 (C+), while our review of NuBloom gives it 66/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
66/100
C
77/100
C+
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | NuBloom | Peter MD |
|---|---|---|
| Semaglutide | From $149/molowest dose rungFull plan terms$149/mo (2.4 mg dose, compounded) | $149/mointro + renewal; see termsFull plan terms$149/mo (GLP1+B12, compounded, first-time tier billed $447 up front for an estimated 10–12 week supply; returning-patient tier $139/mo, billed $834 up front) |
| Tirzepatide | From $279/molowest dose rungFull plan terms$279/mo (15 mg dose, compounded) | $249/moquarterly termFull plan terms$249/mo (60mg, billed quarterly; $149 first month) |
| Coverage | 49 states | Most states (restrictions vary by treatment — tirzepatide excludes AL and ID; semaglutide also excludes AK and HI) |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Not confirmed here | Not confirmed here |
| Best for | Women seeking a physician-founded, whole-person GLP-1 and hormone program with optional 1:1 coaching. | Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes. |
| Desk Score | 66/100C | 77/100C+ |
The verdict
Desk pick — Peter MDPeter MD has the higher Desk Score, but NuBloom may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Women seeking a physician-founded, whole-person GLP-1 and hormone program with optional 1:1 coaching.
Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs NuBloom
- CoreAge Rx vs Peter MD
- NuBloom vs Ondra Health
- Ondra Health vs Peter MD
- NuBloom vs Tyde Wellness
- Peter MD vs Tyde Wellness
Or see the full comparison hub and the complete ranking.